Apparent increases in tumour NAD +  levels induced by treatment with vitamin K 1  or its synthetic substitutes.
D000818:Animals; D002277:Carcinoma / Q000378:metabolism; D005260:Female; D008223:Lymphoma / Q000378:metabolism; D008297:Male; D008545:Melanoma / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D009243:NAD / Q000096:biosynthesis / Q000378:metabolism*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism*; D010954:Plasmacytoma / Q000378:metabolism; D012510:Sarcoma 180 / Q000378:metabolism; D012513:Sarcoma, Experimental / Q000378:metabolism; D010837:Vitamin K 1 / Q000627:therapeutic use*
D009243:NAD; D010837:Vitamin K 1